Galderma launches new Mirvaso Gel pump dispenser

FORTH WORTH, Texas — Galderma Laboratories announced Thursday that it had launched a new pump dispenser system for its Mirvaso (brimonidine) topical gel. The gel treats facial redness associated with rosacea and the new pump dispenses a consistent dose with each use. 

 

“The availability of the Mirvaso Gel pump offers a number of benefits to patients with facial erythema,” Galderma consultant and Arkansas-based dermatologist Dr. Sandra Johnson said. “Research proves that the majority of patients prefer a pump dispenser over a tube. As a frequent prescriber of Mirvaso Gel, I am excited for the introduction of this dosing option that is convenient to use for my patients.”

 

Mirvaso was approved in 2013 as a first-in-class treatment for rosacea-related redness, and according to Galderma it can start working for some patients 30 minutes after application and last up to 12 hours.